NCT00700986View on ClinicalTrials.gov

Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

AZD9056

Oral tablet, 800mg, one single administration

DRUG

Placebo

Single dose

Trial Locations (1)

Unknown

Research Site, Nottingham

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY